Latest filing published 20 Jun 2024 for Cinclus Pharma Holding AB (publ), €6,476.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -51.1%Entry SEK 33.10 · Close at T+365 SEK 16.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Helena Levander: trading record in brief
Helena Levander appears in our data through filings on Cinclus Pharma Holding AB (publ) shares, published by Finansinspektionen. In total, 4 filings cover trades dated 20 June 2024.
Every open-market trade on record is a purchase: 1 purchase worth €6,476, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 20 June 2024, the filings show a transaction worth €68k in Cinclus Pharma Holding AB (publ). The last insider purchase was made public on 20 June 2024, 872 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Helena Levander
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ SEK 36.408.1% of flowAktieISIN SE0020388577FI:csv-42ea08a093732e6833aaCanonical exit: 18 Sept 2024 (T+90)
- 18,300 shares@ SEK 42.0085.0% of flowAktieISIN SE0020388577FI:csv-744f467efdefa5850805
- 1,490 shares@ SEK 42.006.9% of flowAktieISIN SE0020388577FI:csv-85fa15c6bea2863de5db
3 of 3 declarations